▁A 4.50175142288208
▁British 7.6017889976501465
▁ph 7.242138862609863
arma 0.4931275546550751
ce 0.08232138305902481
ut 0.0016319351270794868
ical 0.0004754004185087979
▁company 0.5117979049682617
▁has 1.339406967163086
▁reported 4.199191570281982
▁positive 3.6614718437194824
▁results 0.38128963112831116
▁from 0.3885728120803833
▁its 1.956191062927246
▁clin 2.391451120376587
ical 0.002036378486081958
▁trial 0.4446263909339905
▁of 0.6888092756271362
▁a 0.7695571184158325
▁cancer 4.703083515167236
▁drug 0.7948561906814575
. 1.795460820198059
▁However 5.292726993560791
, 0.10043635964393616
▁anal 4.520272254943848
yst 0.004182968754321337
s 0.015195922926068306
▁have 1.734503149986267
▁expressed 2.4082775115966797
▁ca 2.679874897003174
ution 0.0006735208444297314
, 2.3818960189819336
▁warning 2.4852468967437744
▁that 0.2534785568714142
▁there 3.5178205966949463
▁is 0.995595395565033
▁still 1.1295394897460938
▁a 0.6489590406417847
▁long 0.4573011100292206
▁way 0.1398216038942337
▁to 0.017251325771212578
▁go 0.006434654351323843
▁before 0.3579722046852112
▁the 0.4671887159347534
▁drug 0.8316633701324463
▁can 1.1241788864135742
▁be 0.24287451803684235
▁approved 1.7086889743804932
▁for 0.6389878988265991
▁use 0.5129146575927734
. 0.5960667729377747
<0x0A> 0.16560080647468567
The 0.8990401029586792
▁drug 1.2010258436203003
, 0.29545965790748596
▁developed 4.2072553634643555
▁by 0.008559576235711575
▁British 4.271742820739746
▁Bi 4.502779483795166
ote 0.0073965671472251415
ch 0.14655452966690063
, 2.1002447605133057
▁is 0.6930294036865234
▁designed 1.5876295566558838
▁to 0.0035290331579744816
▁target 1.7275581359863281
▁a 0.6990532279014587
▁specific 1.1136757135391235
▁protein 1.1738718748092651
▁that 0.6242336630821228
▁is 0.09311533719301224
▁found 1.3981748819351196
▁in 0.49727755784988403
▁many 1.5364681482315063
▁types 0.48125404119491577
▁of 0.0013652221532538533
▁cancer 0.05987114831805229
▁cells 0.7674914598464966
. 0.06170649826526642
▁In 2.550001621246338
▁the 0.329153835773468
▁clin 1.3254257440567017
ical 0.00030343368416652083
▁trial 0.007831703871488571
, 0.004196316469460726
▁the 0.28124934434890747
▁drug 0.027134960517287254
▁was 0.17903967201709747
▁tested 2.585397720336914
▁on 0.1684645414352417
▁patients 0.41373157501220703
▁with 0.04589018225669861
▁advanced 0.5037126541137695
- 3.07572603225708
stage 0.0030777682550251484
▁can 2.5700795650482178
cers 0.00042203033808618784
, 1.105299472808838
▁including 1.0557979345321655
▁pan 2.407700538635254
cre 6.270605808822438e-05
atic 0.007434097118675709
▁cancer 1.425167202949524
, 0.7470924854278564
▁breast 3.035451889038086
▁cancer 0.0028216077480465174
, 0.22882093489170074
▁and 0.06293566524982452
▁le 5.1217474937438965
uk 0.8612922430038452
emia 0.005673737730830908
. 0.0026355513837188482
<0x0A> 0.16716721653938293
Acc 3.737248420715332
ording 6.84284750605002e-05
▁to 0.00014079606626182795
▁the 0.1337016522884369
▁company 0.6457998752593994
, 0.10719911009073257
▁the 0.009496638551354408
▁drug 0.43331101536750793
▁showed 1.881436824798584
▁prom 0.5859244465827942
ising 8.535749657312408e-05
▁results 0.007954921573400497
, 1.2636524438858032
▁with 0.04691993445158005
▁some 1.3232053518295288
▁patients 0.004812656901776791
▁experien 0.4462537169456482
cing 2.1100267986184917e-05
▁a 1.0403697490692139
▁reduction 2.277621269226074
▁in 0.000945836422033608
▁the 1.508217453956604
▁size 0.010150333866477013
▁of 0.006255362182855606
▁their 0.004305977839976549
▁tum 0.041759803891181946
ors 0.032865241169929504
▁and 0.6127596497535706
▁surv 11.258064270019531
iving 0.5643424987792969
▁longer 0.2483752816915512
▁than 0.14081723988056183
▁expected 1.2253820896148682
. 0.0054170917719602585
▁However 0.42514440417289734
, 4.7446425014641136e-05
▁the 0.634264349937439
▁trial 1.3877615928649902
▁was 0.21532152593135834
▁relatively 2.2541184425354004
▁small 0.00045649692765437067
, 0.3884005844593048
▁with 0.705230176448822
▁only 0.22106020152568817
▁ 0.20882827043533325
3 1.7041796445846558
0 0.7153810262680054
▁patients 0.03943096846342087
▁taking 1.084591269493103
▁part 0.02516918070614338
, 0.5439257621765137
▁and 0.04536132514476776
▁the 0.8218685984611511
▁drug 3.08496356010437
▁has 1.763235092163086
▁yet 1.198124885559082
▁to 5.018836964154616e-05
▁be 0.06949648261070251
▁tested 0.3879213035106659
▁in 2.055987596511841
▁a 1.926792860031128
▁larger 0.09371647983789444
- 4.207494735717773
scale 0.0002085784071823582
▁trial 0.9104201793670654
. 0.05163831636309624
<0x0A> 0.008275984786450863
Anal 1.0360970497131348
yst 0.00429873401299119
s 0.00043836902477778494
▁have 0.12967659533023834
▁war 0.6903445720672607
ned 1.5139694369281642e-05
▁against 5.228477954864502
▁getting 0.73287034034729
▁too 0.10720820724964142
▁excited 0.09769228845834732
▁about 0.12240750342607498
▁the 0.005406064912676811
▁results 0.5152257680892944
, 0.17813901603221893
▁saying 2.146749258041382
▁that 0.007050395477563143
▁it 3.3877038955688477
▁is 0.039309266954660416
▁still 0.8735743761062622
▁too 0.43487441539764404
▁early 0.02481631189584732
▁in 10.504172325134277
▁the 0.013979720883071423
▁drug 1.1002421379089355
▁development 1.361732006072998
▁process 0.008002806454896927
▁to 0.2778918147087097
▁draw 2.178467273712158
▁any 0.7523743510246277
▁firm 0.4981039762496948
▁conclus 8.547671313863248e-05
ions 8.344684829353355e-06
. 0.038182225078344345
▁They 0.9588040113449097
▁c 7.1112775802612305
ite 1.2569749355316162
▁the 0.35238921642303467
▁fact 1.5187827348709106
▁that 0.00025376916164532304
▁many 3.3371810913085938
▁prom 2.8093552589416504
ising 5.602852525044e-06
▁cancer 1.2063508033752441
▁dru 0.1135144978761673
gs 1.1920930376163597e-07
▁have 0.1033206358551979
▁failed 0.08968889713287354
▁in 0.3261848986148834
▁later 0.9648854732513428
- 1.564558506011963
stage 0.0016216067597270012
▁tri 0.5226770043373108
als 9.536747711536009e-07
, 0.9704259037971497
▁either 4.347740173339844
▁because 0.6264837980270386
▁they 0.13371267914772034
▁did 2.235617160797119
▁not 2.741851312748622e-05
▁work 0.21830351650714874
▁as 0.09097123891115189
▁well 0.29792284965515137
▁as 0.022634044289588928
▁expected 0.7270498275756836
▁or 0.11530399322509766
▁because 0.048087894916534424
▁they 0.04882589727640152
▁had 0.734873354434967
▁un 0.9292757511138916
antic 3.899991750717163
ip 1.835839793784544e-05
ated 1.657022767176386e-05
▁side 0.01145949400961399
▁effects 0.0022501612547785044
. 0.008199239149689674
<0x0A> 0.007175137288868427
In 2.9318723678588867
▁addition 0.5861480832099915
, 0.03412216156721115
▁the 0.8366574048995972
▁analysis 5.60735559463501
▁of 0.971695065498352
▁the 0.5812600255012512
▁trial 2.0798938274383545
▁data 1.270678162574768
▁has 1.3320173025131226
▁not 1.2145912647247314
▁yet 0.7242186665534973
▁been 0.01792164333164692
▁peer 1.5584218502044678
- 0.04062112048268318
review 0.00027380159008316696
ed 0.0002665278734639287
▁or 2.509331464767456
▁published 0.05984444543719292
▁in 0.07617544382810593
▁a 0.004950897768139839
▁medical 1.9639616012573242
▁journal 0.0003227516426704824
, 0.10046292096376419
▁which 0.5775706171989441
▁means 0.6584634184837341
▁that 0.02438734471797943
▁it 1.2649158239364624
▁has 0.7375811338424683
▁not 0.0178848709911108
▁been 0.47057104110717773
▁subject 0.43982067704200745
▁to 0.6226451992988586
▁independent 2.9141602516174316
▁scr 0.08131363242864609
ut 8.583106136939023e-06
iny 0.00021907106565777212
▁from 2.9811389446258545
▁other 0.2379368543624878
▁exper 0.23991920053958893
ts 5.3168758313404396e-05
▁in 0.04475146159529686
▁the 0.00011671271204249933
▁field 0.0003332454652991146
. 0.0030203729402273893
<0x0A> 0.325203001499176
Des 0.5899919867515564
p 6.49711728328839e-05
ite 2.849142583727371e-05
▁these 0.1906787008047104
▁cave 1.0488080978393555
ats 6.926299829501659e-05
, 0.00033706147223711014
▁the 0.40857169032096863
▁news 1.8750758171081543
▁of 0.7897603511810303
▁the 0.23410184681415558
▁positive 0.7002046704292297
▁trial 0.6365970969200134
▁results 0.025585521012544632
▁has 0.20428213477134705
▁led 5.265079498291016
▁to 0.024944208562374115
▁a 1.5519537925720215
▁sur 0.5124995708465576
ge 4.1604907892178744e-05
▁in 0.025598302483558655
▁British 3.019392490386963
▁Bi 0.011114684864878654
ote 0.00041189329931512475
ch 0.002386674052104354
' 1.5124300718307495
s 0.00028942240169271827
▁share 0.3032771050930023
▁price 0.011594435200095177
, 0.17744088172912598
▁as 3.488478899002075
▁invest 0.024934491142630577
ors 0.0001347155775874853
▁hope 1.8042312860488892
▁that 0.036691635847091675
▁the 0.02107548713684082
▁drug 0.1626834273338318
▁will 1.5389788150787354
▁prove 2.454237222671509
▁to 0.14773131906986237
▁be 0.003981997724622488
▁a 0.17615802586078644
▁break 1.3525159358978271
through 1.811997572076507e-05
▁in 0.5467463731765747
▁the 0.18388964235782623
▁fight 0.2824944853782654
▁against 1.9312090444145724e-05
▁cancer 0.0007644236902706325
. 0.0018968681106343865
<0x0A> 0.4852149188518524
The 1.4458924531936646
▁company 0.3436691462993622
▁has 0.6557489633560181
▁said 0.5858631730079651
▁that 0.0076212892308831215
▁it 0.014646396040916443
▁plans 0.28295430541038513
▁to 0.00011873950279550627
▁continue 2.2271759510040283
▁testing 1.9315308332443237
▁the 0.002526790602132678
▁drug 0.0005440403474494815
▁in 0.0364212803542614
▁further 4.5709052085876465
▁tri 1.0958749055862427
als 8.344653679159819e-07
, 0.6696844100952148
▁including 4.195828437805176
▁a 1.0981520414352417
▁larger 0.16777022182941437
- 0.5883665680885315
scale 0.00015629558765795082
▁phase 3.202946662902832
▁II 1.9048120975494385
▁trial 0.12265922129154205
▁that 1.1882309913635254
▁will 1.6801146268844604
▁involve 1.2293264865875244
▁several 2.4164810180664062
▁hundred 0.09671001881361008
▁patients 0.01349495816975832
. 0.04764050990343094
<0x0A> 2.9158828258514404
If 1.7985643148422241
▁the 0.14867401123046875
▁drug 0.23970139026641846
▁continues 2.32797908782959
▁to 2.4557415599701926e-05
▁show 0.08097096532583237
▁prom 0.32623106241226196
ising 2.7180087272427045e-05
▁results 0.002684557344764471
, 1.5417782068252563
▁it 0.2031516283750534
▁could 0.11976500600576401
▁offer 5.7765398025512695
▁a 0.7631127834320068
▁new 0.24824413657188416
▁treatment 0.5506712794303894
▁option 0.0007265464519150555
▁for 0.00227835844270885
▁patients 0.37095847725868225
▁with 0.010859530419111252
▁advanced 0.24597005546092987
- 0.057202938944101334
stage 0.00028047917294315994
▁can 0.1427493840456009
cers 3.564421058399603e-05
▁who 1.3256086111068726
▁currently 1.19197416305542
▁have 0.002246337942779064
▁limited 1.4024009704589844
▁options 0.29486626386642456
. 1.1761672496795654
▁However 0.6092362403869629
, 3.540578472893685e-05
▁it 0.45796284079551697
' 4.924711227416992
s 4.4585267460206524e-05
▁important 0.0803527683019638
▁to 0.0375957228243351
▁note 1.884389877319336
▁that 0.0007739677093923092
▁it 2.4741883277893066
▁will 1.169435977935791
▁be 2.5903759002685547
▁several 0.9112088680267334
▁more 3.321809768676758
▁years 0.0003643699747044593
▁before 0.01850673370063305
▁the 0.07983022183179855
▁drug 0.0046484461054205894
▁is 0.4211624264717102
▁likely 2.221012592315674
▁to 0.00038034998578950763
▁be 0.18262045085430145
▁approved 0.24295786023139954
▁for 0.021187379956245422
▁use 0.04522966966032982
, 1.3747209310531616
▁assuming 7.0588836669921875
▁that 1.5036664009094238
▁it 0.5290733575820923
▁continues 0.780657947063446
▁to 0.0005739189800806344
▁show 0.2129528522491455
▁positive 0.6638171076774597
▁results 0.015104909427464008
▁in 0.11594893783330917
▁later 2.658229112625122
- 0.1638430655002594
stage 0.0009206001996062696
▁tri 0.052545852959156036
als 2.3841887468734058e-06
. 0.02142520807683468
<0x0A> 0.22488154470920563
In 0.7978113889694214
▁the 0.4118492007255554
▁meant 0.011178814806044102
ime 3.4570755360618932e-06
, 3.3379157684976235e-05
▁patients 1.1648114919662476
▁with 0.3814840018749237
▁cancer 1.6488423347473145
▁will 1.1579725742340088
▁continue 0.25488176941871643
▁to 0.0010863480856642127
▁rely 0.2019253969192505
▁on 0.0028919032774865627
▁existing 0.37338653206825256
▁treat 0.20150308310985565
ments 8.10626534075709e-06
, 0.13308551907539368
▁such 1.9579098224639893
▁as 2.7656937163555995e-05
▁chem 0.328273743391037
other 4.3631553126033396e-05
apy 2.5033982637978625e-06
▁and 0.4907448887825012
▁radiation 0.6853802800178528
▁ther 0.07676004618406296
apy 2.0504208805505186e-05
, 0.030677342787384987
▁which 0.37300193309783936
▁can 0.5972946286201477
▁be 0.37272927165031433
▁effective 0.49874967336654663
▁but 0.5342151522636414
▁also 0.6557814478874207
▁have 0.9608439803123474
▁significant 0.16800999641418457
▁side 0.014241838827729225
▁effects 0.00023314094869419932
. 0.039828475564718246
<0x0A> 0.4631117880344391
The 1.938309907913208
▁news 1.1980338096618652
▁of 0.04744849354028702
▁the 0.14805495738983154
▁positive 0.18790434300899506
▁trial 0.31341302394866943
▁results 0.002413560403510928
▁also 5.692113399505615
▁highlight 0.305990993976593
s 0.0015552806435152888
▁the 0.002855619415640831
▁on 1.1874849796295166
going 0.00029926010756753385
▁efforts 2.3928821086883545
▁to 0.5594637393951416
▁develop 0.11229915916919708
▁new 0.01952488347887993
▁and 2.446993350982666
▁better 1.724125623703003
▁treat 0.32120180130004883
ments 1.0371261851105373e-05
▁for 0.00016714539378881454
▁cancer 0.004834398161619902
, 0.624013364315033
▁a 2.470770835876465
▁disease 0.20517663657665253
▁that 0.002250997582450509
▁affect 1.0899478197097778
s 2.8014574127155356e-05
▁millions 0.014676819555461407
▁of 0.00031607376877218485
▁people 0.00029926010756753385
▁around 0.5744386911392212
▁the 2.0265784769435413e-05
▁world 0.0026201331056654453
. 1.1642574071884155
▁While 0.8573719263076782
▁progress 2.878484010696411
▁has 0.12121723592281342
▁certainly 9.824111938476562
▁been 1.7047073924914002e-05
▁made 5.030758256907575e-05
▁in 0.18485932052135468
▁recent 0.0649934634566307
▁years 0.03186517581343651
, 0.005457484163343906
▁as 7.66593599319458
▁seen 2.5847535133361816
▁in 1.5733258724212646
▁the 0.06004595384001732
▁development 0.2618134021759033
▁of 0.004549285396933556
▁new 2.220939874649048
▁imm 0.7991225123405457
un 0.013124867342412472
other 4.94730775244534e-05
apy 0.7013446092605591
▁dru 0.45407745242118835
gs 9.536747711536009e-07
▁and 1.082574725151062
▁other 1.919985055923462
▁target 0.7332988977432251
ed 0.00012338922533672303
▁ther 0.612625777721405
ap 0.00042119549470953643
ies 3.695494797284482e-06
, 0.01354963518679142
▁there 0.126571923494339
▁is 0.024314789101481438
▁still 0.03213799372315407
▁much 1.2827047109603882
▁work 0.09209993481636047
▁to 0.014701618812978268
▁be 0.005433212965726852
▁done 1.633180545468349e-05
▁to 1.1327898502349854
▁improve 0.2530757188796997
▁out 0.8093894124031067
comes 1.0490472050150856e-05
▁for 0.05240049585700035
▁cancer 1.0454200506210327
▁patients 6.83092512190342e-05
. 0.0541529580950737
<0x0A> 0.1673269271850586
As 2.0597341060638428
▁the 1.480439305305481
▁development 3.6271235942840576
▁of 0.07141316682100296
▁new 0.36341962218284607
▁cancer 0.38262927532196045
▁dru 0.4581499695777893
gs 1.0728841743912199e-06
▁continues 0.031244546175003052
, 0.01357700489461422
▁it 0.052794087678194046
' 0.7607451677322388
s 2.30076584557537e-05
▁important 0.12298856675624847
▁for 0.39924201369285583
▁patients 0.13527990877628326
▁and 0.35390183329582214
▁their 0.10192151367664337
▁families 0.17421790957450867
▁to 0.0011730515398085117
▁stay 0.6377497911453247
▁informed 0.02431747503578663
▁about 0.30512022972106934
▁the 0.06291274726390839
▁latest 0.01912345364689827
▁research 0.6674700975418091
▁and 0.031566161662340164
▁to 1.0375515222549438
▁work 0.4471791684627533
▁closely 0.9342653751373291
▁with 5.722062269342132e-06
▁their 0.0010628983145579696
▁health 0.05454780161380768
care 0.013245658949017525
▁prov 0.31914520263671875
iders 2.9325916329980828e-05
▁to 0.008482868783175945
▁explore 5.286686420440674
▁all 0.011108235456049442
▁available 0.3608488440513611
▁treatment 0.06779260188341141
▁options 1.764313128660433e-05
. 0.05145437642931938
<0x0A> 0.7561694979667664
U 4.197268486022949
lt 0.1121632531285286
imately 0.0015193435829132795
, 3.993590871687047e-05
▁the 0.20605723559856415
▁hope 2.279224395751953
▁is 0.005288913380354643
▁that 0.0008330237469635904
▁new 1.5692036151885986
▁cancer 1.8167061805725098
▁dru 0.22821712493896484
gs 4.768372718899627e-07
▁like 0.4533095061779022
▁the 0.25056591629981995
▁one 0.021895797923207283
▁being 0.4311778247356415
▁developed 0.13554075360298157
▁by 0.0008980490965768695
▁British 0.0007923999801278114
▁Bi 0.0028506580274552107
ote 0.0001613031781744212
ch 0.001262806123122573
▁will 0.10726944357156754
▁prove 6.037036895751953
▁to 0.0046722195111215115
▁be 0.0025212932378053665
▁safe 3.221006393432617
▁and 0.06747850030660629
▁effective 0.0004616849182639271
▁treat 2.9787704944610596
ments 1.657022767176386e-05
▁that 0.1411290317773819
▁can 0.11755727976560593
▁improve 1.9765732288360596
▁the 1.0152817964553833
▁lives 0.22603899240493774
▁of 0.002359130885452032
▁millions 4.474368095397949
▁of 0.0004229844198562205
▁people 0.10922760516405106
▁around 0.806175947189331
▁the 9.346444858238101e-05
▁world 0.0033442804124206305
. 0.14929048717021942
▁But 6.030675411224365
▁until 1.3021371364593506
▁then 1.4483516216278076
, 0.00018628186080604792
▁ca 8.810563087463379
ution 2.527268952690065e-05
▁is 0.9491682648658752
▁war 0.4318811297416687
r 0.0001958204375114292
anted 0.00016595311171840876
, 0.4974689781665802
▁and 0.2012062966823578
▁continued 3.947125196456909
▁research 0.5772721767425537
▁and 0.25046756863594055
▁development 1.031012773513794
▁are 1.1903903484344482
▁cru 3.8099660873413086
cial 0.0004287088813725859
. 2.6245265007019043
